Federal Register / Vol. 77, No. 12 / Thursday, January 19, 2012 / Notices 2739 

Name of Committee: Cardiovascular and 

Respiratory Sciences Integrated Review 

Group; Cardiovascular Differentiation and 

Development Study Section. 

Date: February 9, 2012. 

Time: 8 a.m. to 7 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Ritz Carlton Hotel, 1150 22nd Street 

NW., Washington, DC 20037. 

Contact Person: Maqsood A. Wani, Ph.D., 

DVM, Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4136, 

MSC 7814, Bethesda, MD 20892, (301) 435– 

2270, wanimaqs@csr.nih.gov. 

Name of Committee: Digestive, Kidney and 

Urological Systems Integrated Review Group; 

Hepatobiliary Pathophysiology Study 

Section. 

Date: February 13–14, 2012. 

Time: 8 a.m. to 3 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Hyatt Regency Bethesda, One 

Bethesda Metro Center, 7400 Wisconsin 

Avenue, Bethesda, MD 20814. 

Contact Person: Bonnie L. Burgess-Beusse, 

Ph.D., Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 2182, 

MSC 7818, Bethesda, MD 20892, (301) 435– 

1783, beusseb@mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research, 93.306, 93.333, 

93.337, 93.393–93.396, 93.837–93.844, 

93.846–93.878, 93.892, 93.893, National 

Institutes of Health, HHS) 

Dated: January 11, 2012. 

Jennifer S. Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2012–956 Filed 1–18–12; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Heart, Lung, and Blood 

Institute; Notice of Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Heart, Lung, 

and Blood Institute Special Emphasis Panel; 

Genetics of Heart, Lung and Blood Diseases 

Review. 

Date: February 8, 2012. 

Time: 12 p.m. to 3 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892, 

(Telephone Conference Call). 

Contact Person: Michael P. Reilly, Ph.D., 

Scientific Review Officer, Office of Scientific 

Review/DERA, National Heart, Lung, and 

Blood Institute, 6701 Rockledge Drive, Room 

7200, Bethesda, MD 20892, (301) 496–9659, 

reillymp@nhlbi.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.233, National Center for 

Sleep Disorders Research; 93.837, Heart and 

Vascular Diseases Research; 93.838, Lung 

Diseases Research; 93.839, Blood Diseases 

and Resources Research, National Institutes 

of Health, HHS) 

Dated: January 12, 2012. 

Jennifer S. Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2012–955 Filed 1–18–12; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; PAR Panel: 

Blood Cell Therapies. 

Date: February 7–8, 2012. 

Time: 11 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

(Virtual Meeting). 

Contact Person: Bukhtiar H Shah, DVM, 

Ph.D., Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4120, 

MSC 7802, Bethesda, MD 20892, (301) 806– 

7314, shahb@csr.nih.gov. 

Name of Committee: Oncology 2— 

Translational Clinical Integrated Review 

Group; Cancer Immunopathology and 

Immunotherapy Study Section. 

Date: February 9–10, 2012. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Crowne Plaza Old Town Alexandria, 

901 North Fairfax Street, Alexandria, VA 

22314. 

Contact Person: Denise R Shaw, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 6158, 

MSC 7804, Bethesda, MD 20892, (301) 435– 

0198, shawdeni@csr.nih.gov. 

Name of Committee: Digestive, Kidney and 

Urological Systems Integrated Review Group; 

Kidney Molecular Biology and Genitourinary 

Organ Development. 

Date: February 9, 2012. 

Time: 8 a.m. to 6 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Crowne Plaza Washington National 

Airport, 1480 Crystal Drive, Arlington, VA 

22202. 

Contact Person: Ryan G Morris, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4205, 

MSC 7814, Bethesda, MD 20892, (301) 435– 

1501, morrisr@csr.nih.gov. 

Name of Committee: Biobehavioral and 

Behavioral Processes Integrated Review 

Group; Language and Communication Study 

Section. 

Date: February 13, 2012. 

Time: 8 a.m. to 6 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Doubletree Guest Suites Santa 

Monica, 1707 Fourth Street, Santa Monica, 

CA 90401. 

Contact Person: Weijia Ni, Ph.D., Scientific 

Review Officer, Center for Scientific Review, 

National Institutes of Health, 6701 Rockledge 

Drive, Room 3184, MSC 7848, Bethesda, MD 

20892, (301) 237–9918, niw@csr.nih.gov. 

Name of Committee: Endocrinology, 

Metabolism, Nutrition and Reproductive 

Sciences Integrated Review Group; Molecular 

and Cellular Endocrinology Study Section. 

Date: February 13, 2012. 

Time: 8 a.m. to 6 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Hyatt Regency Bethesda, One 

Bethesda Metro Center, 7400 Wisconsin 

Avenue, Bethesda, MD 20814. 

Contact Person: John Bleasdale, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 6170, 

MSC 7892, Bethesda, MD 20892, (301) 435– 

4514, bleasdaleje@csr.nih.gov. 

Name of Committee: Genes, Genomes, and 

Genetics Integrated Review Group; Molecular 

Genetics A Study Section. 

Date: February 13–14, 2012. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

mstockstill on DSK4VPTVN1PROD with NOTICES

2740 Federal Register / Vol. 77, No. 12 / Thursday, January 19, 2012 / Notices 

Place: Hyatt Regency Bethesda, One 

Bethesda Metro Center, 7400 Wisconsin 

Avenue, Bethesda, MD 20814. 

Contact Person: Michael M Sveda, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 1114, 

MSC 7890, Bethesda, MD 20892, (301) 435– 

3565, svedam@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; 

Computational Modeling and Sciences for 

Biomedical and Clinical Applications. 

Date: February 13, 2012. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Hyatt Regency Bethesda, One 

Bethesda Metro Center, 7400 Wisconsin 

Avenue, Bethesda, MD 20814. 

Contact Person: Guo Feng Xu, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5122, 

MSC 7854, Bethesda, MD 20892, (301) 237– 

9870, xuguofen@csr.nih.gov. 

Name of Committee: Cell Biology 

Integrated Review Group; Biology of the 

Visual System Study Section. 

Date: February 13–14, 2012. 

Time: 8 a.m. to 5:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Hyatt Regency Bethesda, One 

Bethesda Metro Center, 7400 Wisconsin 

Avenue, Bethesda, MD 20814. 

Contact Person: Michael H Chaitin, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5202, 

MSC 7850, Bethesda, MD 20892, (301) 435– 

0910, chaitinm@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Member 

Conflict: Bone and Cartilage Biology. 

Date: February 13, 2012. 

Time: 2 p.m. to 4 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892, 

(Telephone Conference Call). 

Contact Person: Baljit S Moonga, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4214, 

MSC 7806, Bethesda, MD 20892, (301) 435– 

1777, moongabs@mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research, 93.306, 93.333, 

93.337, 93.393–93.396, 93.837–93.844, 

93.846–93.878, 93.892, 93.893, National 

Institutes of Health, HHS). 

Dated: January 12, 2012. 

Jennifer S. Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2012–953 Filed 1–18–12; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Neurological 

Disorders and Stroke Notice of Closed 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable materials, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Neurological Disorders and Stroke Initial 

Review Group; Neurological Sciences and 

Disorders B. 

Date: February 23, 2012. 

Time: 8 a.m. to 6 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Hotel Monaco Alexandria, 480 King 

Street, Alexandria, VA 22314. 

Contact Person: Birgit Neuhuber, Ph.D., 

Scientific Review Officer, Scientific Review 

Branch, Division of Extramural Research, 

National Institute of Neurological Disorders 

and Stroke, NIH, NSC, 6001 Executive Blvd., 

Room 3202, MSC 9529, Bethesda, MD 20892– 

9529, (301) 496–3562 

neuhuber@ninds.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.853, Clinical Research 

Related to Neurological Disorders; 93.854, 

Biological Basis Research in the 

Neurosciences, National Institutes of Health, 

HHS.) 

Dated: January 12, 2012. 

Jennifer S. Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2012–952 Filed 1–18–12; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Substance Abuse and Mental Health 

Services Administration 

Agency Information Collection 

Activities: Submission for OMB 

Review; Comment Request 

Periodically, the Substance Abuse and 

Mental Health Services Administration 

(SAMHSA) will publish a summary of 

information collection requests under 

OMB review, in compliance with the 

Paperwork Reduction Act (44 U.S.C. 

Chapter 35). To request a copy of these 

documents, call the SAMHSA Reports 

Clearance Officer on (240) 276–1243. 

Project: Toolkit Protocol for the Crisis 

Counseling Assistance and Training 

Program (CCP)—Revision 

The Substance Abuse and Mental 

Health Services Administration’s 

(SAMHSA) Center for Mental Health 

Services (CMHS) will create a toolkit to 

be used for the purposes of collecting 

data on the Crisis Counseling Assistance 

and Training Program (CCP). The CCP 

provides supplemental funding to states 

and territories for individual and 

community crisis intervention services 

during a Federal disaster. 

The CCP has provided disaster mental 

health services to millions of disaster 

survivors since its inception and, as a 

result of 30 years of accumulated 

expertise, it has become an important 

model for Federal response to a variety 

of catastrophic events. State CCPs, such 

as the recent 2009 Project A’apa Atu (for 

the Tsunami in American Samoa), 2010 

Tennessee Recovery Project (following 

devastating flooding), Healing Joplin 

and Project Rebound (following the 

2011 tornadoes in Joplin, Missouri and 

Alabama), and most recently the 

multiple CCPs that resulted from 2011 

Hurricane Irene, and flooding 

throughout the summer of 2011 have 

primarily addressed the short-term 

mental health needs of communities 

through (a) Outreach and public 

education, (b) individual and group 

counseling, and (c) referral. Outreach 

and public education serve primarily to 

normalize reactions and to engage 

people who might need further care. 

Crisis counseling assists survivors to 

cope with current stress and symptoms 

in order to return to predisaster 

functioning. Crisis counseling relies 

largely on ‘‘active listening,’’ and crisis 

counselors also provide psychoeducation (especially about the nature 

of responses to trauma) and help clients 

build coping skills. Crisis counseling 

typically continues no more than a few 

times. Because crisis counseling is timelimited, referral is the third important 

function of CCPs. Counselors are 

expected to refer clients to formal 

treatment if the person has developed 

more serious psychiatric problems. 

Data about services delivered and 

users of services will be collected 

throughout the program period. The 

data will be collected via the use of a 

toolkit that relies on standardized forms. 

At the program level, the data will be 

entered quickly and easily into a 

mstockstill on DSK4VPTVN1PROD with NOTICES